Le Lézard
Classified in: Health
Subject: FDA

Q'Apel Medical Announces FDA Clearance for Walrus Balloon Guide Catheter


FREMONT, Calif., July 17, 2019 /PRNewswire/ -- Q'Apel Medical announced today that it received U.S. Food and Drug Administration clearance for its novel walrus Balloon Guide Catheter (BGC). 

Logo

In the neurovascular space where speed, reliability and performance are so critical to patient outcomes, physicians and patients demand that innovative technologies are best-in-class. The walrus BGC, with its 087 ID, marks a big step forward in balloon guide catheter technology and for stroke patients worldwide. 

"Catheter compatibility in the neurovascular space is critical to the treatment of stroke patients. Until now, widespread adoption of BGCs has been limited due to technical constraints. The walrus BGC was specifically designed to address these technical shortcomings with an 087 ID in a highly trackable catheter platform," said Raymond Turner MD, professor of neurosurgery at Prisma Health. "I expect its introduction will be welcomed by neurovascular physicians everywhere." 

The walrus BGC represents the second FDA-cleared technology from Q'Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q'Apel's expanding product portfolio. Q'Apel has several more innovative products slated to come to market over the course of the next year. 

About Q'Apel Medical LLC

Q'Apel Medical LLC is a medical device company founded with the sole purpose of developing best-in-class technology for neurovascular interventions. Learn more about Q'Apel at www.option3llc.com/portfolio.

For more information about Q'Apel and the walrus BGC, please email info@option3llc.com.

Related Images

qapel-medical.jpg

SOURCE Q'Apel Medical


These press releases may also interest you

at 11:01
New Ocean Health Solutions (New Ocean),  leading provider of enterprise health management solutions for employers, health plans and health systems announced today that their digital engagement platform and supporting technologies have earned...

at 11:01
SCAN Health Plan®, one of the nation's largest not-for-profit Medicare Advantage plans, today announced it has provided its senior sensitivity training, Trading Ages, to all firefighters in the City of Long Beach. Engaging 400 participants over 21...

at 11:00
There are so many paths that R&D is taking in the ongoing fight against cancer. New drugs, new therapies and new techniques are developed to help researchers and practitioners across all cancer sub-markets. One such tool that is showing increased...

at 11:00
Stayhealthy, the first company to combine patented healthcare solutions with augmented reality technology, and OncoGambit, the first computer-aided individualized cancer treatment confirmation resource, announced today the launch of a new mobile...

at 11:00
Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, today announced new Cybersecurity resources for members within their Operational Continuity and...

at 11:00
Healthfuse, the industry leader in managing and sourcing revenue cycle vendors for hospitals and health systems, today announced a top-line growth of 40 percent in 2019. "We had solid growth in 2019, accelerating our momentum of providing revenue...



News published on 17 july 2019 at 00:39 and distributed by: